MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,210,000 | +233.3% | 17,329 | +220.1% | 0.04% | +168.8% |
Q2 2022 | $363,000 | -83.1% | 5,413 | -79.3% | 0.02% | -84.2% |
Q1 2022 | $2,148,000 | +445.2% | 26,124 | +871.5% | 0.10% | +320.8% |
Q4 2021 | $394,000 | -49.7% | 2,689 | -44.6% | 0.02% | -63.6% |
Q2 2021 | $783,000 | -63.4% | 4,850 | -50.2% | 0.07% | -70.9% |
Q4 2020 | $2,140,000 | +217.0% | 9,742 | +12.4% | 0.23% | +291.4% |
Q3 2019 | $675,000 | +79.0% | 8,665 | +136.7% | 0.06% | +70.6% |
Q2 2019 | $377,000 | +27.8% | 3,660 | -47.4% | 0.03% | +88.9% |
Q4 2018 | $295,000 | -63.9% | 6,964 | -73.9% | 0.02% | -68.4% |
Q1 2018 | $818,000 | +266.8% | 26,650 | -37.8% | 0.06% | +96.6% |
Q1 2017 | $223,000 | +77.0% | 42,879 | +62.2% | 0.03% | +45.0% |
Q4 2016 | $126,000 | -12.5% | 26,432 | +21.1% | 0.02% | -37.5% |
Q3 2016 | $144,000 | -45.2% | 21,833 | -54.7% | 0.03% | -8.6% |
Q2 2016 | $263,000 | -72.2% | 48,178 | +61.1% | 0.04% | -57.8% |
Q4 2015 | $945,000 | -23.9% | 29,900 | -17.2% | 0.08% | -22.4% |
Q3 2015 | $1,242,000 | – | 36,100 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |